Chapter 4.Antipsychotic Drugs
Sections
Excerpt
Observations in the late nineteenth century that aniline dyes had calming and sedating effects ultimately led to the development of the first phenothiazine, promethazine. In 1952, a related phenothiazine, chlorpromazine, was investigated as an antiautonomic drug to protect the body against its own excessive compensatory reactions during major surgery. It spread into psychiatry from the field of anesthesia after an initial clinical report by Delay et al. (1952) demonstrated the drug’s favorable side-effect profile and its efficacy in treating acute psychosis. Endless subsequent double-blind studies have served chiefly to confirm the effects already obvious to the original French clinicians.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).